* CareMax Inc CMAX.OQ CMAX.O is expected to show a rise
in
quarterly revenue when it reports results on November 9.
* The Miami Florida-based company is expected to report a
34.8% increase in revenue to $140.981 million from $104.62
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for CareMax Inc is for
a loss
of 6 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for CareMax Inc
is
$10, above its last closing price of $6.08.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.05 -0.05 -0.11 Missed -106.3
Mar. 31 2022 -0.02 -0.02 -0.19 Missed -660
Dec. 31 2021 -0.06 -0.06 -0.04 Beat 33.3
Sep. 30 2021 -0.08 -0.08 -0.03 Beat 63.6
Jun. -0.04 -0.04 -0.26 Missed -550
30 2021
This summary was machine generated November 7 at 17:19 GMT. All
figures in US dollars unless otherwise stated